Price
CHART BY
Frequently asked questions
What is the Earnings Per Share (EPS) for Alexion Pharms?
Alexion Pharms's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 3.057. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Alexion Pharms's stock?
Currently, 1 analysts cover Alexion Pharms's stock, with a consensus target price of $175.00. Analyst ratings provide insights into the stock's expected performance.
What is Alexion Pharms's revenue over the trailing twelve months?
Over the trailing twelve months, Alexion Pharms reported a revenue of $6.28B.
What is the EBITDA for Alexion Pharms?
Alexion Pharms's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $3.28B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Alexion Pharms?
Alexion Pharms has a free cash flow of $2.98B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Alexion Pharms have, and what sector and industry does it belong to?
Alexion Pharms employs approximately 3,837 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
Financials
- EPS (TTM)
- 3.057
- Revenue (TTM)
- $6.28B
- EBITDA (TTM)
- $3.28B
- Free Cashflow (TTM)
- $2.98B
Analyst Ratings
The price target is $175.00 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.
- Employees
- 3,837
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- ALXN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet